BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aiyasiding X, Liao HH, Feng H, Zhang N, Lin Z, Ding W, Yan H, Zhou ZY, Tang QZ. Liquiritin Attenuates Pathological Cardiac Hypertrophy by Activating the PKA/LKB1/AMPK Pathway. Front Pharmacol 2022;13:870699. [PMID: 35592411 DOI: 10.3389/fphar.2022.870699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zuo H, Li L, Wang X, Chen S, Liao Z, Wei S, Ruan H, Li T, Chen J. A novel circ_0018553 protects against angiotensin-induced cardiac hypertrophy in cardiomyocytes by modulating the miR-4731/SIRT2 signaling pathway. Hypertens Res 2022. [DOI: 10.1038/s41440-022-01111-y] [Reference Citation Analysis]
2 Han X, Yang Y, Zhang M, Li L, Xue Y, Jia Q, Wang X, Guan S. Liquiritin Protects Against Cardiac Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway. Drug Des Devel Ther 2022;16:4111-25. [PMID: 36483459 DOI: 10.2147/DDDT.S386805] [Reference Citation Analysis]
3 Xie Y, Sui W, Qin S, Yao Q, Fan D, Li T, Wang F, Fu X, Zhang L. Pinoresinol diglucoside alleviates pressure overload-induced cardiac injury via the AMPK/SIRT3/RIG-1 pathway.. [DOI: 10.21203/rs.3.rs-2245921/v1] [Reference Citation Analysis]
4 Lu Q, Ding Y, Liu Y, Wang Z, Wu Y, Niu K, Li K, Zhang J, Sun H. Metrnl ameliorates diabetic cardiomyopathy via inactivation of cGAS/STING signaling dependent on LKB1/AMPK/ULK1-mediated autophagy. Journal of Advanced Research 2022. [DOI: 10.1016/j.jare.2022.10.014] [Reference Citation Analysis]
5 Molaei A, Molaei E, Sadeghnia H, Hayes AW, Karimi G. LKB1: An emerging therapeutic target for cardiovascular diseases. Life Sci 2022;306:120844. [PMID: 35907495 DOI: 10.1016/j.lfs.2022.120844] [Reference Citation Analysis]